Medtronic Puts Its 2014 Tyrx Buy To The Test With Large Study
This article was originally published in The Gray Sheet
Executive Summary
The 7,000-patient WRAP-IT study will measure the clinical and cost benefits of employing the Tyrx antibacterial envelope, acquired by Medtronic last year, to reduce infections following cardiac rhythm management device implant procedures. Medtronic hopes to leverage new incentives for hospitals to cut infection rates.